CStone Pharmaceuticals Reports 2022 Annual Results and Business Updates
- Written by PR Newswire
- The total revenue for 2022 was RMB 481.4 million, with commercial revenue of RMB 394.1 million, which represents a 142% increase compared to the previous year
- Healthy financial position with cash reserves of RMB 1.042 billion as of December 31, 2022. The net loss has decreased by 55% from the previous year
- Two new products successfully launched...
Read more: CStone Pharmaceuticals Reports 2022 Annual Results and Business Updates














